UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2683) 2683
life sciences & biomedicine (2584) 2584
humans (1933) 1933
animals (1455) 1455
glucagon-like peptide-1 receptor (1221) 1221
endocrinology & metabolism (1161) 1161
male (1145) 1145
diabetes mellitus, type 2 - drug therapy (1052) 1052
type 2 diabetes (923) 923
diabetes (903) 903
glucagon (892) 892
glucagon-like peptide-1 (842) 842
hypoglycemic agents - therapeutic use (804) 804
glucagon-like peptide-1 receptor - agonists (768) 768
receptors, glucagon - agonists (669) 669
peptides (644) 644
female (638) 638
insulin (550) 550
mice (549) 549
glucose (537) 537
pharmacology & pharmacy (508) 508
rats (501) 501
peptides - pharmacology (477) 477
receptors, glucagon - metabolism (461) 461
glucagon-like peptide 1 (456) 456
liraglutide (443) 443
diabetes mellitus (439) 439
middle aged (423) 423
hypoglycemic agents - pharmacology (422) 422
glucagon-like peptide-1 receptor - metabolism (405) 405
biological and medical sciences (374) 374
glucagon-like peptide 1 - metabolism (373) 373
venoms - pharmacology (372) 372
exenatide (351) 351
endocrine system (336) 336
analysis (330) 330
digestive, oral, and skin physiology (325) 325
obesity (325) 325
blood glucose - metabolism (312) 312
glucagon-like peptide 1 - analogs & derivatives (309) 309
abridged index medicus (306) 306
glp-1 (299) 299
hypoglycemic agents - adverse effects (296) 296
hypoglycemic agents - administration & dosage (293) 293
insulin - metabolism (291) 291
diabetes mellitus, type 2 - blood (287) 287
peptides - therapeutic use (286) 286
aged (285) 285
treatment outcome (284) 284
hormones, hormone substitutes, and hormone antagonists (282) 282
diabetes mellitus, type 2 - metabolism (281) 281
adult (276) 276
glucagon-like peptide 1 - pharmacology (276) 276
medical sciences (273) 273
internal medicine (270) 270
biochemistry & molecular biology (263) 263
research (263) 263
dextrose (261) 261
blood glucose - drug effects (260) 260
physiological aspects (260) 260
rodents (254) 254
care and treatment (248) 248
hypoglycemic agents (246) 246
risk factors (246) 246
dipeptidyl-peptidase iv inhibitors - therapeutic use (244) 244
mice, inbred c57bl (237) 237
medicine & public health (234) 234
type 2 diabetes mellitus (229) 229
rats, sprague-dawley (224) 224
insulin resistance (223) 223
glucagon-like peptide 1 - therapeutic use (222) 222
insulin secretion (215) 215
incretins - therapeutic use (214) 214
body weight (211) 211
health aspects (211) 211
diabetes therapy (210) 210
venoms - therapeutic use (205) 205
diabetes mellitus, type 2 - complications (200) 200
physiology (191) 191
clinical trials (187) 187
endocrinopathies (186) 186
receptors, glucagon - genetics (186) 186
drug therapy (183) 183
endocrine pancreas. apud cells (179) 179
signal transduction - drug effects (179) 179
general & internal medicine (177) 177
neurosciences (177) 177
diabetes. impaired glucose tolerance (176) 176
signal transduction (175) 175
cardiovascular system & cardiology (173) 173
medicine, research & experimental (172) 172
research & experimental medicine (172) 172
peptides - administration & dosage (170) 170
cell line (169) 169
incretin (169) 169
medicine, general & internal (169) 169
glucagon-like peptide-1 receptor agonist (168) 168
etiopathogenesis. screening. investigations. target tissue resistance (163) 163
neurosciences & neurology (163) 163
exendin-4 (162) 162
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3186) 3186
Spanish (25) 25
Japanese (24) 24
German (17) 17
Chinese (12) 12
French (12) 12
Italian (8) 8
Russian (6) 6
Danish (4) 4
Czech (3) 3
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article